Kolon Life Science Inc. (KOSDAQ: 102940)

Kolon Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13,263	7,561	6,371	27,800	15,001	5,914
Short-Term Investments	-	-	-	110	30	15,000
Cash & Short-Term Investments	13,263	7,561	6,371	27,910	15,031	20,914
Cash Growth	16.21%	18.68%	-77.17%	85.69%	-28.13%	29.92%
Accounts Receivable	27,299	24,605	29,440	19,649	22,199	28,526
Other Receivables	920.87	1,008	302.04	638.16	398.12	931.53
Receivables	28,220	25,613	29,742	20,287	22,597	29,457
Inventory	48,027	67,777	68,494	45,998	42,790	36,064
Prepaid Expenses	5,034	3,406	4,579	3,743	7,237	4,441
Other Current Assets	649.23	688.31	998.16	82.57	12,908	284.2
Total Current Assets	95,192	105,045	110,184	98,021	100,563	91,160
Property, Plant & Equipment	126,532	123,138	125,960	131,481	141,893	178,398
Long-Term Investments	116,595	77,054	75,240	2,549	3,262	2,143
Goodwill	-	-	1,217	1,217	1,217	1,217
Other Intangible Assets	500.32	168.28	58.95	99.11	199.79	258.57
Long-Term Accounts Receivable	-0	0	-0	-0	-0	-0
Long-Term Deferred Charges	74.71	164.25	283.64	403.04	522.43	641.82
Other Long-Term Assets	3,689	3,866	1,174	888.54	680.57	4,477
Total Assets	342,583	309,436	314,118	234,658	248,338	278,295
Accounts Payable	10,631	11,547	17,049	13,774	11,808	10,714
Accrued Expenses	4,988	4,355	3,594	3,145	2,721	1,898
Short-Term Debt	110,257	97,262	69,461	59,064	61,751	53,742
Current Portion of Long-Term Debt	-	-	4,000	5,333	5,333	6,520
Current Portion of Leases	794.02	428.66	287.62	336.45	348.65	233.03
Current Income Taxes Payable	-	-	376.36	-	-	-
Current Unearned Revenue	13,201	3,201	3,201	3,500	3,500	3,500
Other Current Liabilities	47,186	11,547	11,608	10,316	59,689	49,565
Total Current Liabilities	187,056	128,341	109,578	95,469	145,152	126,173
Long-Term Debt	-	9,980	-	4,000	9,333	18,095
Long-Term Leases	1,453	191.33	167.18	191.02	262.15	142.56
Long-Term Deferred Tax Liabilities	17,314	9,874	9,760	-	-	-
Other Long-Term Liabilities	16,215	16,938	17,078	25,139	25,903	25,249
Total Liabilities	229,533	171,764	146,395	135,248	190,381	177,274
Common Stock	6,212	5,706	5,706	5,706	5,706	5,706
Additional Paid-In Capital	228,594	209,114	209,114	209,542	167,980	167,980
Retained Earnings	-209,742	-133,289	-101,537	-106,024	-104,359	-61,361
Treasury Stock	-	-	-	-812.88	-812.88	-812.88
Comprehensive Income & Other	87,986	56,140	54,440	-9,001	-10,557	-10,493
Total Common Equity	113,050	137,672	167,723	99,410	57,957	101,020
Shareholders' Equity	113,050	137,672	167,723	99,410	57,957	101,020
Total Liabilities & Equity	342,583	309,436	314,118	234,658	248,338	278,295
Total Debt	112,504	107,863	73,916	68,925	77,029	78,733
Net Cash (Debt)	-99,241	-100,301	-67,545	-41,015	-61,998	-57,820
Net Cash Per Share	-8492.62	-8788.83	-5344.94	-3597.74	-5438.33	-5071.55
Filing Date Shares Outstanding	12.42	11.41	11.41	11.4	11.4	11.4
Total Common Shares Outstanding	12.42	11.41	11.41	11.4	11.4	11.4
Working Capital	-91,864	-23,296	606.75	2,552	-44,589	-35,013
Book Value Per Share	9099.77	12063.41	14696.64	8720.06	5083.88	8861.31
Tangible Book Value	112,550	137,504	166,448	98,094	56,541	99,545
Tangible Book Value Per Share	9059.50	12048.67	14584.86	8604.64	4959.63	8731.90
Land	16,281	16,281	17,286	17,008	17,024	22,009
Buildings	64,832	88,069	88,567	88,891	88,874	108,745
Machinery	19,138	104,638	101,589	102,952	90,469	90,101
Construction In Progress	23,953	17,810	16,474	15,952	28,846	30,798

Source: S&P Capital IQ. Standard template. Financial Sources.